Prix Galien – Medstartup : Historic double victory for ProtecSom-OptimHal !

Official : Following its nomination, Laboratoire ProtecSom-OptimHal announces its double victory, in partnership with Virginia Commonwealth University, l’Association Pulmonaire in Québec and PharmaSystems in two categories of the 2017 Prix Galien – MedstartUp, organized by the Galien Foudation and Business France.

An internationally recognized prestigious award

Dedicated to innovation since 1970, the Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation that improves the state of human health.

The most innovative Franco-American collaborations have been awarded during the Prix Galien – MedstartUp ceremony on Thursday 26 October in New-York.

A rigorous selection dedicated to global excellence

Following a drastic selection, only  11 out of 50 companies were nominated for the innovative aspect of their healthcare solutions.

ProtecSom-OptimHal laboratory was rewarded for :

« The Best Collaboration with academia Leading to a Breakthrough Solution »

A partnership with the Virginia Commonwealth University, Professor Bruce Rubin and PharmaSystems Inc.

« The Best Use of Patient Engagement Technologies »

A partnership with L’Association Pulmonaire in Québec and PharmaSystems Inc.

This historic victory is a great achievement for ProtecSom-OptimHal, thus proving recognition for its efforts in terms of innovation for healthcare.

A word from the Scientific Director 

« I am very proud of these two successes and I congratulate our research teams for the quality of their work that has enabled these partnerships. This is an important asset for our company on American soil where we find ourselves partners with Professor Bruce Rubin whose life is dedicated to the health of children. » – Thierry Porée

We would like to thank all our partners that contributed to the success of our project and without whom nothing could have been possible : Professor Bruce RubinBusiness FranceCCI NormandieAssociation Pulmonaire in QuébecPharmaSystems

Share this article